APA (7th ed.) Citation

NA, K., M, J., N, C., S, L., C, B., R, N., . . . T, A. (2023). Vaccine escape, increased breakthrough and reinfection in infliximab-treated patients with IBD during the Omicron wave of the SARS-CoV-2 pandemic. Gut, 72(2), 295. https://doi.org/10.1136/gutjnl-2022-327570

Chicago Style (17th ed.) Citation

NA, Kennedy, et al. "Vaccine Escape, Increased Breakthrough and Reinfection in Infliximab-treated Patients with IBD During the Omicron Wave of the SARS-CoV-2 Pandemic." Gut 72, no. 2 (2023): 295. https://doi.org/10.1136/gutjnl-2022-327570.

MLA (9th ed.) Citation

NA, Kennedy, et al. "Vaccine Escape, Increased Breakthrough and Reinfection in Infliximab-treated Patients with IBD During the Omicron Wave of the SARS-CoV-2 Pandemic." Gut, vol. 72, no. 2, 2023, p. 295, https://doi.org/10.1136/gutjnl-2022-327570.